Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder – expert consensus survey part 2
Martha Sajatovic,1,2 Ruth Ross,3 Susan N Legacy,4 Matthew Byerly,5 John M Kane,6,7 Faith DiBiasi,8 Heather Fitzgerald,9 Christoph U Correll6,7 1Department of Psychiatry, University Hospitals Cleveland Medical Center, Cleveland, OH, USA; 2Departments of Psychiatry and Neurology, Case Western Reserve...
Saved in:
Main Authors: | Sajatovic M, Ross R, Legacy SN, Byerly M, Kane JM, DiBiasi F, Fitzgerald H, Correll CU |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/2c62a36e694a43ad96447d90b73743d5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics – expert consensus survey part 1
by: Sajatovic M, et al.
Published: (2018) -
Attitudes toward antipsychotic treatment among patients with bipolar disorders and their clinicians: a systematic review
by: Sajatovic M, et al.
Published: (2017) -
Patterns of Thyroid Hormone Prescription in Patients with Bipolar or Schizoaffective Disorder: Findings from the LiSIE Retrospective Cohort Study
by: Ingrid Lieber, et al.
Published: (2021) -
Therapy of Schizoaffective Disorder and Paranoid Schizophrenia with Episodic Course
by: L. A. Ivanova, et al.
Published: (2019) -
Taiwan Expert Consensus Recommendations for Switching to Aripiprazole Long-Acting Once-Monthly in Patients with Schizophrenia
by: Chih-Sung Liang, et al.
Published: (2021)